NCT02204254View on ClinicalTrials.gov

RosaC-RF : Bipolar Radiofrequency vs Doxycycline in Rosacea

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2018

Study Completion Date

June 7, 2021

Conditions
Rosacea
Interventions
DEVICE

Radiofrequence

Associated to arm radiofrequence

DRUG

Doxycycline

doxycycline 100 mg / day for 3 months with clinical evaluation, photos, and confocal SSSB V1 and V4 (M6). Tour V2 M1 for clinical evaluation of safety review, collection of adverse events and issuing end of treatment. Visit V3 M3 on adverse effects.

Trial Locations (1)

06200

CRC, Hôpital de l'Archet, 151 route de saint-ginestière, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT02204254 - RosaC-RF : Bipolar Radiofrequency vs Doxycycline in Rosacea | Biotech Hunter | Biotech Hunter